SCHEMBL3096439

SCHEMBL3096439

O=C(c1ccc(Cl)cc1)N1CCN(C2CN(C(=O)c3cc4ccccc4o3)CC2O)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.60
▸ CA12 O43570 1/20 0.56
▸ CA1 P00915 1/20 0.56
▸ CA2 P00918 1/20 0.56
▸ CA7 P43166 1/20 0.56
▸ CA9 Q16790 1/20 0.56
▸ HPGD P15428 3/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ RECQL P46063 1/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ USP2 O75604 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ MEN1 O00255 1/20 0.53
▸ GLA P06280 1/20 0.53
▸ GAA P10253 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ POLB P06746 1/20 0.52
▸ HRH4 Q9H3N8 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13157900 1.00 ALDH1A1 (0.60) ALDH1A1CA12CA1CA2CA7
SCHEMBL3092446 0.91 HRH4 (0.58) ALDH1A1CA12CA1CA2CA7
SCHEMBL13158090 0.91 HRH4 (0.58) ALDH1A1CA12CA1CA2CA7
SCHEMBL13157902 0.87 GRIN2B (0.57) ALDH1A1HPGDNPSR1MAPTMEN1
SCHEMBL3093260 0.87 GRIN2B (0.57) ALDH1A1HPGDNPSR1MAPTMEN1
SCHEMBL3105142 0.83 POLB (0.55) ALDH1A1CA12CA1CA2CA7
SCHEMBL13157795 0.83 POLB (0.55) ALDH1A1CA12CA1CA2CA7
SCHEMBL13158203 0.83 POLB (0.55) ALDH1A1CA12CA1CA2CA7
SCHEMBL13158093 0.83 ALDH1A1 (0.49) ALDH1A1HPGDNPSR1MAPTRECQL
SCHEMBL3107629 0.83 ALDH1A1 (0.49) ALDH1A1HPGDNPSR1MAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399455-B2 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-03-19 — — US disclosed
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS ACKR3, CCR5, CXCR2 ALDH1A1 1889/4885CA12 2348/4885CA1 2416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback